AHL Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.3M | Buy |
94,702
+2,920
| +3% | +$70.8K | 1.53% | 25 |
|
|
2025
Q1 | $2.33M | Buy |
91,782
+6,345
| +7% | +$161K | 1.6% | 24 |
|
|
2024
Q4 | $2.27M | Buy |
85,437
+550
| +0.6% | +$14.6K | 1.59% | 22 |
|
|
2024
Q3 | $2.46M | Buy |
84,887
+10,784
| +15% | +$312K | 1.69% | 22 |
|
|
2024
Q2 | $2.07M | Buy |
74,103
+936
| +1% | +$26.2K | 1.52% | 24 |
|
|
2024
Q1 | $2.03M | Buy |
73,167
+4,440
| +6% | +$123K | 1.56% | 27 |
|
|
2023
Q4 | $1.98M | Hold |
68,727
| – | – | 1.62% | 26 |
|
|
2023
Q3 | $2.28M | Buy |
68,727
+5,971
| +10% | +$198K | 2.03% | 19 |
|
|
2023
Q2 | $2.3M | Buy |
62,756
+10,407
| +20% | +$382K | 2.05% | 18 |
|
|
2023
Q1 | $2.14M | Buy |
52,349
+34
| +0.1% | +$1.39K | 1.97% | 17 |
|
|
2022
Q4 | $2.68M | Sell |
52,315
-1,841
| -3% | -$94.3K | 2.49% | 14 |
|
|
2022
Q3 | $2.37M | Buy |
54,156
+5,205
| +11% | +$228K | 2.44% | 15 |
|
|
2022
Q2 | $2.57M | Buy |
48,951
+445
| +0.9% | +$23.3K | 2.58% | 14 |
|
|
2022
Q1 | $2.51M | Sell |
48,506
-720
| -1% | -$37.3K | 2.3% | 16 |
|
|
2021
Q4 | $2.91M | Buy |
+49,226
| New | +$2.91M | 2.65% | 13 |
|